Joaquín Castilla Selected Research

Ciclopirox (Loprox)

5/2021	Improving the Pharmacological Properties of Ciclopirox for Its Use in Congenital Erythropoietic Porphyria.
1/2018	Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joaquín Castilla Research Topics

Disease

43	Prion Diseases (Transmissible Spongiform Encephalopathies) 03/2024 - 01/2004
17	Infections 06/2021 - 05/2004
15	Scrapie 01/2023 - 03/2005
14	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 01/2005
11	Bovine Spongiform Encephalopathy (Mad Cow Disease) 10/2022 - 05/2004
7	Chronic Wasting Disease 08/2019 - 08/2008
4	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 01/2013
4	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 04/2015 - 06/2009
3	Parkinson Disease (Parkinson's Disease) 01/2018 - 09/2015
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2017 - 01/2013
2	Gliosis 01/2023 - 01/2021
2	Brain Diseases (Brain Disorder) 12/2021 - 01/2015
2	Pathologic Processes 12/2021 - 01/2013
2	Erythropoietic Porphyria (Congenital Erythropoietic Porphyria) 05/2021 - 01/2018
2	Communicable Diseases (Infectious Diseases) 09/2015 - 01/2013
1	Autoimmune Diseases (Autoimmune Disease) 10/2020
1	Amyloidosis 01/2017
1	Amyloid Plaque 09/2015
1	Fatal Familial Insomnia 04/2015
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2013
1	Proteostasis Deficiencies 03/2006
1	Neuroblastoma 03/2005
1	Asymptomatic Infections 05/2004

Drug/Important Bio-Agent (IBA)

46	PrionsIBA 12/2021 - 05/2004
41	Prion ProteinsIBA 03/2024 - 05/2004
16	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2005
10	Protein Isoforms (Isoforms)IBA 01/2023 - 06/2009
6	Amino Acids FDA Link 01/2020 - 12/2013
5	Amyloid (Amyloid Fibrils)IBA 01/2018 - 07/2005
2	Peptide Hydrolases (Proteases)FDA Link 01/2023 - 01/2016
2	Endopeptidase K (Proteinase K)IBA 06/2021 - 01/2004
2	Biomarkers (Surrogate Marker)IBA 06/2021 - 01/2020
2	EnzymesIBA 05/2021 - 01/2018
2	Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA 05/2021 - 01/2018
2	Ciclopirox (Loprox)FDA LinkGeneric 05/2021 - 01/2018
2	Heme (Haem)IBA 05/2021 - 01/2018
2	Codon (Codons)IBA 10/2020 - 03/2013
2	Isoleucine (L-Isoleucine)FDA Link 10/2017 - 03/2013
2	Methionine (L-Methionine)FDA Link 10/2017 - 03/2013
1	Polysaccharides (Glycans)IBA 10/2022
1	tau Proteins (tau Protein)IBA 12/2021
1	alpha-SynucleinIBA 12/2021
1	MicroRNAs (MicroRNA)IBA 06/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	ferric oxide (iron oxide)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 10/2020
1	AutoantibodiesIBA 10/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	SolutionsIBA 01/2020
1	AntigensIBA 05/2017
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2017
1	meso- tetrakis(1- methyl- 4- pyridiniumyl)porphyrinIBA 03/2016
1	Protein AggregatesIBA 09/2015
1	AA amyloidosisIBA 09/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2007
1	AntioxidantsIBA 06/2007
1	UbiquinoneIBA 06/2007
1	coenzyme Q10 (CoQ10)IBA 06/2007
1	LipidsIBA 06/2007
1	Small Interfering RNA (siRNA)IBA 03/2005
1	PrPSc ProteinsIBA 05/2004

Therapy/Procedure

2	Therapeutics 03/2016 - 01/2013
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2015